Global Epilepsy Brand Lead — Hybrid & Launch Expert

UCB

Reading

Hybrid

GBP 120,000 - 180,000

Full time

5 days ago
Be an early applicant

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

UCB is seeking a Global Brand Head Epilepsy Brands to maximize the value of its epilepsy portfolio, including BRIVIACT, VIMPAT, KEPPRA, and NAYZILAM. You will shape and execute robust strategies, identify opportunities, and drive lifecycle and launch excellence to support sustainable growth and improved patient care.

You will collaborate with stakeholders across Commercial, Medical, Market Access, Supply, Regulatory, Clinical, HEOR, and Insights, influencing global direction and coordinating

Qualifications

  • Bachelor's degree required; Master's degree preferred.
  • Extensive experience in the pharmaceutical, biotechnology, or medical device industry.
  • Several years' country or regional leadership experience.
  • Strong global marketing, strategic planning, commercialization, and launch experience.
  • Proven cross-functional leadership, influencing, communication, and relationship-building capabilities.
  • Experience developing global strategies, business cases, and complex projects.

Responsibilities

  • Lead global commercial strategies across UCB's epilepsy brand portfolio.
  • Drive launch, lifecycle, and integrated strategic planning across markets.
  • Translate patient, customer, and market insights into growth opportunities.
  • Align cross-functional stakeholders around portfolio priorities and coordinated execution.
  • Guide forecasting, investment decisions, risk mitigation, and performance optimization.
  • Advance digital, AI-driven, and innovative commercialization approaches globally.

Skills

Global brand leadership
Strategic planning
Launch experience
Cross-functional leadership
Communication
Relationship-building

Education

Bachelor's degree
Master's degree

Job description

UCB is seeking a Global Brand Head Epilepsy Brands to maximize the value of its epilepsy portfolio, including BRIVIACT, VIMPAT, KEPPRA, and NAYZILAM. You will shape and execute robust strategies, identify opportunities, and drive lifecycle and launch excellence to support sustainable growth and improved patient care.

You will collaborate with stakeholders across Commercial, Medical, Market Access, Supply, Regulatory, Clinical, HEOR, and Insights, influencing global direction and coordinating

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Global Epilepsy Brand Lead — Strategy & Growth
Global Epilepsy Brand Lead — Strategy & Growth

UCB • City Of London

Hybrid
GBP 120,000 - 160,000
Global Brand Lead, Epilepsy - Hybrid & High-Impact
Global Brand Lead, Epilepsy - Hybrid & High-Impact

UCB • Slough

Hybrid
GBP 120,000 - 180,000
Global Brand Head (m/f/d) Epilepsy (UK)
Global Brand Head (m/f/d) Epilepsy (UK)

UCB • Reading

Hybrid
GBP 120,000 - 180,000
Global Brand Head (m/f/d) Epilepsy (UK)
Global Brand Head (m/f/d) Epilepsy (UK)

UCB • City Of London

Hybrid
GBP 120,000 - 160,000
Global Brand Head (m/f/d) Epilepsy (UK)
Global Brand Head (m/f/d) Epilepsy (UK)

UCB • Slough

Hybrid
GBP 120,000 - 180,000
Regional Market Access Lead for Epilepsy
Regional Market Access Lead for Epilepsy

ACTalent • Taunton

Hybrid
GBP 50,000 - 70,000
Remote Global Medical Director, Epilepsy Pipeline
Remote Global Medical Director, Epilepsy Pipeline

Jazz Pharmaceuticals, Inc. • Greater London

Remote
GBP 180,000 - 240,000
Neurology Clinical BD Lead - Partnering & Evaluation
Neurology Clinical BD Lead - Partnering & Evaluation

UCB • Slough

Hybrid
GBP 110,000 - 140,000
Global Medical Lead, Migraine & Neuroscience (Hybrid)
Global Medical Lead, Migraine & Neuroscience (Hybrid)

Ipsen Biopharm Ltd • Greater London

Hybrid
GBP 150,000 - 250,000
Global Access & Pricing Strategy Lead - Neurology
Global Access & Pricing Strategy Lead - Neurology

UCB • Slough

Hybrid
GBP 90,000 - 130,000